How large is HCA Healthcare by revenue and market capitalization?

HCA Healthcare is a large-cap healthcare company with annual revenues running well into the tens of billions of dollars. In Q2 2026 alone, the company reported revenue of $20.23 billion, reflecting year-over-year growth of 8.7%. Extrapolating across a full year, the company's own narrowed 2026 guidance points to revenue in the range of $77.0 billion to $79.5 billion, which positions it among the largest revenue-generating companies in the domestic healthcare sector. Market capitalization fluctuates with the share price and is visible on the live instrument page. What the revenue figure establishes is the operational scale: HCA runs a hospital system large enough that even modest shifts in reimbursement rates, patient volumes, or labor costs translate into meaningful dollar swings in earnings. This scale also gives the company purchasing leverage with medical supply vendors and the ability to invest in technology and facility upgrades that smaller regional hospital operators may not afford.

What were HCA Healthcare's Q2 2026 earnings results?

HCA Healthcare posted Q2 2026 revenue of $20.23 billion, an increase of 8.7% compared to the same period a year earlier. Net income attributable to the company reached approximately $1.7 billion for the quarter. Diluted earnings per share came in at $7.62, while adjusted EPS was reported at $7.59. Adjusted EBITDA for the quarter was $4.027 billion. These figures reflect continued top-line growth driven by higher patient volumes and pricing. The EBITDA figure is a widely watched metric in hospital company analysis because it strips out capital structure differences and depreciation, giving a cleaner view of operating cash generation from the facility network. Despite the solid quarterly numbers, the company simultaneously updated its full-year outlook, which introduced some caution among analysts who monitor the stock. The Q2 results and the guidance revision together shaped the market's interpretation of HCA's near-term trajectory.

Why did HCA Healthcare lower its full-year 2026 guidance in July 2026?

HCA Healthcare reduced its full-year 2026 guidance, narrowing its revenue outlook to a range of $77.0 billion to $79.5 billion. The guidance revision reflected the company's updated expectations for patient volume trends, payer mix dynamics, and cost pressures over the remainder of the year. Hospital operators frequently adjust annual guidance mid-year as they accumulate more data on seasonal admissions patterns and reimbursement developments. A key factor in any hospital system's guidance adjustment is the trajectory of uninsured and underinsured patient volumes. When more patients lack adequate coverage, the share of care that goes unreimbursed or is reimbursed at low Medicaid rates rises, compressing margins. Labor costs, particularly for nursing and specialty staff, are another persistent expense driver that can prompt guidance changes. Investors typically scrutinize the width and direction of a guidance revision closely. A narrowed range signals more visibility, but a lowered midpoint signals that management's expectations for profitability have become more conservative than they were at the start of the year.

What is payer mix and why does it matter for HCA's profitability?

Payer mix refers to the proportion of a hospital's patient revenue derived from different categories of payers: commercial insurers, Medicare, Medicaid, and self-pay patients. For HCA Healthcare, payer mix is a primary determinant of realized revenue per patient day, because each category reimburses at materially different rates. Commercial insurance typically pays the highest rates, followed by Medicare, then Medicaid, with self-pay patients generating the least collectible revenue. A shift toward more commercially insured patients improves revenue per equivalent admission and expands margins, all else being equal. Conversely, a growing share of Medicaid or uninsured patients reduces average reimbursement and raises the risk of bad debt expense. Because HCA operates in states with diverse insurance and Medicaid expansion landscapes, the mix can vary significantly by region and by quarter. Analysts tracking HCA pay close attention to same-facility payer mix data disclosed in earnings releases, because even a modest percentage-point shift toward lower-reimbursing payers can have an outsized impact on EBITDA given the company's revenue base in the tens of billions of dollars annually.

How does Medicare and Medicaid reimbursement affect HCA Healthcare's stock price?

Medicare and Medicaid reimbursement rates are set or heavily influenced by federal and state governments, and changes to those rates flow directly into HCA's revenue and margins. Medicare covers elderly and disabled patients, while Medicaid covers low-income populations. Together these programs account for a substantial portion of HCA's patient volume, so regulatory decisions on annual payment updates can meaningfully alter the company's financial outlook. When the Centers for Medicare and Medicaid Services publishes proposed or final rules on inpatient prospective payment rates, hospital stocks including HCA often react in the session following the announcement. A rate increase above inflation can support earnings estimates, while a below-inflation update or an adverse coverage policy can pressure them. Medicaid funding at the state level adds another layer of variability, since state budgets and Medicaid expansion decisions differ across HCA's operating footprint. Because these reimbursement frameworks are subject to annual updates and periodic legislative intervention, the stock carries a persistent policy risk component. Traders and investors following HCA monitor legislative activity around federal healthcare spending, Medicaid eligibility rules, and Medicare Advantage payment structures as part of their analysis.

What is uninsured patient volume and how does it impact HCA's margins?

Uninsured patient volume measures the number of patients who receive care without any insurance coverage. For HCA Healthcare, care delivered to uninsured patients creates a revenue recognition challenge: the company records charges, but collection rates on self-pay accounts are far lower than on insured accounts. A portion of these charges is ultimately written off as charity care or bad debt, which reduces net revenue and compresses operating margins. Rises in uninsured volume can stem from economic downturns that cause job losses and loss of employer-sponsored insurance, from changes in Medicaid eligibility rules that remove some individuals from coverage, or from demographic shifts in the communities around HCA facilities. Because HCA operates a large number of facilities in markets with varied socioeconomic profiles, the aggregate uninsured rate across the network can fluctuate meaningfully from one quarter to the next. Management teams and analysts watch uninsured admission trends closely because even a small percentage increase in uninsured volume, when applied across HCA's scale, translates into hundreds of millions of dollars in potential revenue at risk. This metric often appears in earnings commentary when the company explains guidance changes or margin variability.

How does HCA Healthcare compare to Tenet Healthcare as an investment?

HCA Healthcare and Tenet Healthcare both operate acute-care hospital networks in the United States, but they differ substantially in scale, financial structure, and geographic concentration. HCA is considerably larger by revenue, operating more facilities and generating a revenue base that, per its own 2026 guidance, is projected in the range of $77.0 billion to $79.5 billion for the full year. Tenet operates a smaller network and has historically carried a heavier debt load relative to its earnings base, which makes it more sensitive to interest rate movements. From a margin perspective, HCA has generally demonstrated stronger EBITDA margins, reflecting its scale advantages in labor contracting, supply procurement, and administrative cost allocation. Tenet has pursued a strategy that includes a significant ambulatory surgery center business through its USPI unit, giving it a different revenue mix profile than HCA's more hospital-centric model. For traders accessing HCA price exposure through a CFD on CoinUnited, the relevant comparison is how each company's exposure to payer mix, uninsured volumes, and regulatory reimbursement changes may drive divergent stock price behavior. Neither company is immune to healthcare policy risk, but their different sizes, debt structures, and facility mixes mean they may respond differently to the same macro or regulatory event.

Is HCA Healthcare a growth stock or a value stock?

HCA Healthcare carries characteristics of both categories, making a clean classification difficult. On the growth side, the company reported Q2 2026 revenue of $20.23 billion, up 8.7% year over year, a pace that exceeds the broader healthcare sector's typical expansion rate. Management also pursues active capital deployment through facility construction and acquisitions, which supports a reinvestment narrative associated with growth-oriented companies. On the value side, HCA operates in a mature, capital-intensive industry with relatively predictable, though regulated, revenue streams. Its earnings profile, dividend history, and consistent share repurchase activity are characteristics that value-focused analysts often screen for. In practice, market participants apply different frameworks depending on where the macro cycle sits: when interest rates are elevated, the capital intensity of hospital operators tends to attract value-style scrutiny rather than growth-style multiples. The stock does not fit neatly into one bucket.

What are the main risks of investing in for-profit hospital companies like HCA?

For-profit hospital operators face a layered set of risks that distinguish them from other healthcare sub-sectors. Reimbursement risk is primary: Medicare and Medicaid rates are set by federal and state authorities, and any revision to fee schedules or coverage rules directly compresses margins. HCA's payer mix, the proportion of patients covered by government programs versus commercial insurance, is therefore a constant variable for analysts. Operational risks include labor cost inflation, particularly for nursing staff, which has been a sector-wide pressure in recent years. Capital intensity is also significant; maintaining and expanding hospital networks requires sustained debt financing, leaving operators exposed when borrowing costs rise. Regulatory and litigation risk adds another layer: billing audits, compliance obligations, and fraud-and-abuse statutes create ongoing legal exposure. Finally, uninsured patient volume introduces bad debt that cannot be fully recovered, creating margin variability that is difficult to model precisely.

How sensitive is HCA Healthcare's stock to interest rate changes?

HCA Healthcare carries meaningful sensitivity to interest rate movements for two distinct reasons. First, the company maintains a substantial long-term debt load to fund its capital-intensive hospital network, so higher rates increase refinancing costs and reduce free cash flow available for buybacks and investment. When benchmark yields rise, the US 10-year Treasury yield stood at 4.79% as of early September 2026, the present value of future earnings streams also declines, which tends to pressure equity valuations. Second, rate levels influence the broader equity multiple applied to healthcare stocks. In a higher-rate environment, investors typically demand a wider margin of safety from capital-heavy businesses, compressing price-to-earnings ratios. Conversely, rate cuts can re-rate the sector positively. Because HCA's capital structure relies on periodic debt issuance, market participants watch Federal Reserve guidance closely as part of their assessment of the company's cost of capital trajectory.

What is HCA Healthcare's adjusted EBITDA and why do analysts focus on it?

HCA Healthcare reported adjusted EBITDA of $4.027 billion in Q2 2026. Adjusted EBITDA, earnings before interest, taxes, depreciation, and amortization, with certain one-time items removed, is the metric analysts most commonly use to evaluate hospital operators because it strips out non-cash charges and financing decisions that can obscure underlying operational performance. For a company like HCA, which carries substantial depreciation related to its physical infrastructure, GAAP net income can understate the cash-generating capacity of the business. Adjusted EBITDA allows comparisons across periods and across peers on a like-for-like basis, and it is the figure most frequently cited in debt covenants and credit analyses. Management also uses it internally for capital allocation decisions. Because it excludes interest expense, it separates operational performance from the consequences of the company's leverage strategy, which is useful when evaluating whether the core hospital business is improving or deteriorating independently of financing choices.

How does HCA Healthcare generate revenue — inpatient versus outpatient?

HCA Healthcare generates revenue through two primary channels: inpatient services, where patients are formally admitted and occupy a hospital bed, and outpatient services, where patients receive care without an overnight stay. Historically, inpatient admissions carried higher per-episode revenue due to the intensity of services involved, surgeries, critical care, complex diagnostics. However, the industry-wide trend has been a gradual shift toward outpatient procedures, driven by advances in minimally invasive techniques, payer preferences for lower-cost settings, and regulatory incentives. For HCA, this shift matters because outpatient revenue per encounter is generally lower than inpatient, though volume can be higher and capital requirements per procedure are often less. The company has expanded its ambulatory surgery center network and freestanding emergency facilities to capture outpatient volume. Payer mix interacts with this split as well: commercial insurers typically reimburse at higher rates than government programs for both inpatient and outpatient services, so the relative weighting of payers within each channel shapes overall margin outcomes.

What is the difference between HCA Healthcare CFDs and buying HCA shares?

A CoinUnited HCA Healthcare CFD provides price exposure that tracks the underlying stock without conferring any ownership interest. A trader holding the CFD does not become a shareholder, receives no voting rights, and is not entitled to dividends. The position is a contract whose value moves in line with HCA's market price, settled in crypto rather than through a traditional brokerage account. Buying HCA shares on a stock exchange transfers actual equity ownership. The shareholder holds a fractional claim on the company's assets, participates in any dividend distributions, and can vote on corporate matters. The regulatory framework, custody arrangements, and tax treatment also differ materially. CFDs can be structured with leverage, which amplifies both gains and losses relative to an unlevered share purchase, and positions can be held long or short with equal mechanical ease. The choice between instruments involves considerations of cost, capital efficiency, regulatory access, and risk appetite, each structure carries its own characteristics independent of HCA's performance as a business.

How does weekend gap risk affect HCA Healthcare CFD traders?

The CoinUnited HCA Healthcare CFD follows a scheduled trading session and is closed at weekends. This means that any news, earnings releases, regulatory announcements, macroeconomic data, or sector-specific developments, that reaches markets between Friday's close and Monday's open cannot be acted upon through the platform in real time. When the session reopens, the price may reflect a significant move relative to where a position was entered, creating what traders call a gap. For leveraged CFD positions, gap risk is amplified. A position sized with high leverage can move past a stop-loss level before the market opens, resulting in a realized loss larger than the pre-set risk parameter intended to contain. Healthcare stocks are particularly exposed to this dynamic because material announcements, legislative changes, FDA decisions, or earnings pre-announcements, often occur outside regular session hours. Traders managing open HCA CFD positions over a weekend should account for this structural exposure. The specific session times and holiday calendar are displayed on the CoinUnited platform before order entry.

What happens to an HCA CFD position during US market holidays?

The CoinUnited HCA Healthcare CFD observes US market holidays and is closed during those sessions. An open position held into a holiday period remains on the books but cannot be modified, closed, or added to through the platform while the session is halted. Any price-relevant news that emerges during the holiday closure will be reflected in the opening price when trading resumes. This creates a risk profile similar to, though sometimes shorter in duration than, the weekend gap. For traders using leverage, the inability to manage a position in real time during a closure is a material consideration. Margin requirements remain in effect on open positions regardless of whether the market is trading, so account balances should be sufficient to sustain the position through any potential adverse move at reopening. The full holiday calendar applicable to this instrument is available on the CoinUnited platform. Traders are advised to review the session schedule before entering positions that may span a US market holiday.

How does leverage work when trading HCA Healthcare CFDs?

When trading HCA Healthcare via a CFD on CoinUnited, leverage allows a trader to hold a position with a notional value larger than the capital deposited as margin. The CFD tracks the price of HCA Healthcare stock; any movement in that underlying price produces a proportionally amplified gain or loss relative to the margin held. Because the instrument is a CFD, it confers no shareholding, voting rights, or dividend entitlement, it is purely price exposure. The amplification cuts symmetrically: a 1% move in HCA's price produces a much larger percentage change in the trader's margin balance at high leverage ratios. This means losses can accrue rapidly when the position moves against the trader, and the account is subject to liquidation if margin falls below the required threshold. Healthcare stocks like HCA can also experience sharp intraday moves around earnings releases, guidance revisions, or policy news, all of which interact directly with leveraged exposure. Traders should review the session calendar on the platform, as the HCA CFD follows scheduled trading hours and is closed at weekends.

What is the maximum leverage for HCA Healthcare CFDs on CoinUnited?

The maximum leverage available on the CoinUnited HCA Healthcare CFD is 800x, subject to product terms, jurisdiction, and individual account eligibility. At 800x, a $1,000 margin deposit controls a notional position of $800,000. The arithmetic is exact: notional value equals margin multiplied by the leverage ratio. This specification carries a significant risk dimension. At 800x, a price movement of just 0.125% against the position would, in principle, eliminate the entire margin. HCA Healthcare stock is exposed to periodic volatility events, earnings releases, guidance updates, and healthcare policy developments, that can produce moves well above that threshold within a single session. Leverage amplifies losses as directly as it amplifies gains, and positions can be liquidated automatically if margin requirements are breached. Traders should understand the liquidation mechanism before opening any leveraged position. Trading fees also apply and are tiered by 30-day contract volume; the full schedule is available at https://coinunited.io/en/account/trading-fees.

How do earnings releases affect HCA Healthcare's stock price volatility?

HCA Healthcare's quarterly earnings releases are among the most significant recurring catalysts for short-term price volatility in its stock. The company reports revenue, net income, adjusted EBITDA, earnings per share, and full-year guidance simultaneously, and the market's reaction depends heavily on how actual figures compare to prior expectations. For context, HCA reported Q2 2026 revenue of $20.23 billion, up 8.7% year over year, with adjusted EPS of $7.59 and adjusted EBITDA of $4.027 billion. Despite solid headline numbers, guidance revisions can drive price moves independently of reported results. For CFD traders, earnings dates represent concentrated risk periods. A leveraged position that is profitable before a release can move sharply against the trader within minutes of the announcement. Because the HCA CFD follows a scheduled session and is closed at weekends, any earnings release that occurs after the regular session close creates a gap risk at the next open, the price at which a position can be closed may differ materially from the pre-release price. Reviewing the trading session calendar on the platform before holding a leveraged position through a scheduled earnings date is a practical consideration.

How do I calculate position size when trading HCA Healthcare with leverage?

Position size in a leveraged CFD is the product of the margin committed and the leverage ratio applied. If a trader allocates $500 in margin and applies 100x leverage, the notional exposure is $50,000. Every percentage point move in HCA's price then produces a $500 change in the position's value, equal to the full margin. The same arithmetic applies at any leverage level, so the calculation is: notional value = margin × leverage, and profit or loss per price movement = notional value × percentage price change. For HCA specifically, position sizing should account for the stock's sensitivity to sector-level events: policy announcements, payer-mix shifts, and earnings revisions can each produce rapid price swings. A commonly used approach is to determine the maximum dollar loss tolerable, then work backward to a margin and leverage combination that keeps that threshold achievable. The HCA CFD follows a scheduled session and does not trade at weekends, so overnight and weekend gap exposure affects how positions held across sessions behave. Trading fees, which are tiered by 30-day contract volume, also reduce net returns on each round trip; the full fee schedule is at https://coinunited.io/en/account/trading-fees. All figures should be verified against the live platform before executing.

Navigate to Other Instruments

HCAHCA Healthcare, Inc.

Quick Links

Position Calculator

Position Size (USD)Leverage

Margin Required

$10.00

P&L if HCA moves

+1%+$10.00

+5%+$50.00

+10%+$100.00

Start Trading

HCA Healthcare, Inc.

HCA

$426.06

-0.38% (24h)

StocksTier CTradeable on CoinUnited.io800x Leverage

Today's SignalNext earnings2026-10-22Latest quarter revenue$19.11BQ1 2026Gross margin15.2%Q2 2026

How can you trade HCA Healthcare, Inc.? HCA Healthcare, Inc. (HCA) is publicly listed. On CoinUnited, eligible users can trade a HCA stock CFD — price exposure that tracks the share price. It is a price CFD, not equity (no shareholder voting; dividends reflected as an adjustment) — with leverage, from US$100. Access terms vary by jurisdiction and product eligibility.

How to trade it

Trading stock CFDs on CoinUnited + strategy

Trading Regime Status

Leverage

800x

(Max on CoinUnited.io)

Volatility

Normal

(3.31% 24h)

How the HCA CFD works

Before you trade, understand exactly what you get, what you don't, and where the risk sits.

What you buy

Price exposure to the HCA reference (a synthetic CFD) that tracks the CoinUnited reference up and down.

What you do NOT get

It is not equity: no shares, no voting rights; dividends are reflected as an adjustment, not paid to you.

Basis / session risk

The CoinUnited reference tracks the share price but can differ from the exchange price; extended-hours liquidity is thinner.

Leverage illustration: with $100 margin at 800× leverage you open a $80,000 notional position; if price moves against you to the liquidation level the position is force-closed. High leverage magnifies both profit and liquidation risk.

Trading conditions on CoinUnited

Fee schedule as of 2026-08-19

Product type	CFD	Synthetic price exposure. You do not hold the underlying asset.
Trading fee	0.070%	Per side, at the standard tier. Falls with 30-day volume and reaches 0.000% at VIP 9.
Trading hours	Market session	Follows the market session and is closed at weekends and on market holidays.
Leverage — intraday	800x	During active trading hours. Requires 0.063% margin at the smallest position size. Availability and the maximum depend on product, jurisdiction and account eligibility; leverage amplifies losses and positions can be liquidated.
Leverage — overnight	10x	For a position held beyond the trading day. Requires 5.000% margin at the smallest position size.
Leverage — weekends & holidays	10x	For a position held through a market closure. Requires 5.000% margin at the smallest position size — check your position size before carrying it into a weekend.
Direction	Long or short	Take a position in either direction. A short position profits when the price falls and loses when it rises.
Funding	Crypto deposit	Fund and withdraw in crypto. No bank transfer or card is required.

See the full fee schedule →

Trading HCA Healthcare CFDs on CoinUnited.io

A CoinUnited HCA CFD provides directional price exposure to HCA Healthcare's market price. It does not confer shareholding, voting rights, or dividend entitlement. Profit and loss are determined entirely by the difference between entry and exit price, scaled by position size and leverage multiplier, the mechanics of a standard contract-for-difference.

Session Structure and Gap Risk

The HCA CFD follows a scheduled trading session aligned with US equity market hours. It is closed at weekends and on US market holidays. The session and holiday calendar are displayed on the platform before you trade. Traders accustomed to crypto instruments, which trade continuously, should note this distinction explicitly.

Weekend gap risk is a concrete exposure unique to session-based instruments. Any material development published between Friday's close and Monday's open, a regulatory announcement, a Medicare reimbursement policy change, an earnings pre-release, or a significant macro data print, can produce a price gap at the open that bypasses stop-loss orders set during the closed period.

A stop placed at Friday's close offers no execution guarantee if the stock opens materially away from that level on Monday.

The practical implication: position sizing decisions made on a Thursday or Friday should account for the additional gap exposure over the weekend interval, not only the intraday volatility profile.

Earnings Events as Discrete Volatility Catalysts

For HCA specifically, the quarterly earnings cycle is the highest-volatility period for CFD holders. HCA's Q2 2026 results, reported in July 2026, illustrate the dynamic clearly. The company's revenue guidance revision and the reported figures moved the stock materially within a single session.

Traders holding positions through that announcement without appropriately sized stops faced intraday swings that compressed margin headroom quickly.

The pattern is structural, not incidental. HCA's revenue is sensitive to payer mix, hospital admission volumes, and government reimbursement rates, all of which are disclosed with precision at earnings, generating abrupt re-pricing as the market updates its estimates. Pre-announcement position sizing and explicit stop placement are therefore primary decisions, not secondary ones.

Leverage Mechanics: A Worked Example

The maximum leverage available on the HCA CFD is 800x, subject to product, jurisdiction, and account eligibility conditions. Leverage amplifies both gains and losses proportionally, and positions can be liquidated if margin is exhausted.

The arithmetic of 800x leverage is straightforward but requires precision:

Input	Value
Margin deposited	$100
Leverage multiplier	800x
Notional exposure controlled	$80,000
Adverse move to full margin loss	0.125%

Step by step: a $100 margin at 800x controls $80,000 of notional HCA exposure. A 0.125% adverse price move against the position produces a $100 loss, the full margin. At that point, the position is subject to liquidation.

A 1% adverse move on the same notional would represent eight times the initial margin; without sufficient additional balance, the position would be liquidated well before that point.

This arithmetic makes position sizing relative to total account equity the primary risk control, ahead of any specific price-level analysis.

Traders monitoring broader macroeconomic conditions, including periods of global growth downgrade and stagflation risk, should factor elevated fundamental uncertainty into their notional exposure decisions, not only technical stop distances.

Fee Considerations for Short-Term Positioning

Trading fees on the HCA CFD are not zero at the standard tier. The fee schedule is tiered by 30-day contract volume across nine VIP levels, with the full rate table available at coinunited.io/en/account/trading-fees.

For short-term or high-frequency positioning, where positions are opened and closed within the same session or across a small number of sessions, fees compound across each round trip and should be incorporated into cost-of-carry calculations before entry, not reconciled afterward.

⚡800x💰Fees down to 0%⏱️10s Start

Ready to Trade HCA?

Up to 800x leverage

Trade HCA Now

Key facts & how to trade

The essentials + how you access it on CoinUnited

Access & Tradability Comparison

A CoinUnited stock CFD vs holding the underlying shares — how, when, and in what form you get exposure. The stock price is everywhere; this comparison is the differentiator.

Terms	CoinUnited (CFD)	Holding shares (exchange)
Product form	Stock CFD (price exposure)	Equity ownership
Trading hours	Market session	Exchange regular hours
Leverage	Available (by product terms)	None / margin account needed
Shareholder rights	None (no voting; dividends as adjustment)	Voting + dividends
Access	Eligible users, by region + product	Brokerage account required

*Access and minimum vary by jurisdiction and product eligibility.

Key Facts

The most-cited facts about this company, each with its source — the quick-reference box for readers and AI answer engines.

Primary source: Wikidata

Founded	1968
Headquarters	Nashville
Industry	health care
Listing status	Publicly listed: HCAExchange
Market cap	$95B (as of 2026-09-13)CoinUnited reference x SEC shares
P/E	~15.1CoinUnited reference / SEC annual EPS
52-week range	$349.32 – $556.39CoinUnited daily kline
Next earnings	2026-10-22Finnhub
CoinUnited product	Stock CFD — price exposure, not equity (no voting; dividends reflected as adjustment); leverage availableCoinUnited product terms

Price & Market Structure

24H Range: $419.915→$434.035

24H Low

$419.915

24H High

$434.035

BID / ASK

$425.82 / $426.3

Loading chart...

Company & financials

Business model + audited SEC financials

What Is HCA Healthcare, Inc. (HCA)?

TL;DR

HCA Healthcare is the largest investor-owned hospital operator in the United States, with quarterly revenues exceeding $20 billion and a market capitalization near $92 billion, making it a benchmark name for traders seeking exposure to large-cap healthcare services.

HCA Healthcare, Inc. is the largest investor-owned operator of hospitals and related healthcare facilities in the United States. The company organizes its operations across two primary geographic divisions, providing a broad range of inpatient and outpatient hospital services, surgery centers, physician clinics, and ancillary care lines to patients across the country.

For a trader, a CFD position on HCA stock represents price exposure to this business, not ownership of shares, voting rights, or entitlement to dividends.

Business Model and Revenue Structure

HCA's revenue base is anchored in hospital services. Inpatient admissions, overnight stays requiring acute care, and outpatient procedures together constitute the core of the company's billings. Supplementary revenue comes from freestanding surgery centers, employed physician groups, and ancillary services such as laboratory and imaging.

The payer mix is a defining profitability lever. Revenue is collected from a combination of government programs (Medicare and Medicaid) and commercial insurers, with commercial payers generally reimbursing at higher rates.

Shifts in the proportion of commercially insured versus government-covered patients can materially affect margins, making payer-mix disclosures in quarterly earnings a closely watched variable for equity analysts and traders alike.

Financial Scale: Q2 2026 and Full-Year Guidance

As of September 2026, HCA's financial profile reflects a large-scale, growing enterprise. The company reported Q2 2026 revenue of $20.23 billion, an increase of 8.7% year over year, according to Reuters. Net income attributable to HCA for the quarter was approximately $1.7 billion, with adjusted EBITDA of $4.027 billion.

For the full year 2026, the company has narrowed its revenue guidance to a range of $77.0 billion to $79.5 billion, with adjusted EBITDA guidance of $15.4 billion to $16.1 billion. These figures establish a concrete sense of scale: HCA operates at an annualized revenue run-rate that places it among the largest companies in the US healthcare services sector.

Metric	Q2 2026	FY 2026 Guidance
Revenue	$20.23 billion	$77.0–$79.5 billion
Adjusted EBITDA	$4.027 billion	$15.4–$16.1 billion
Net Income (attributable)	~$1.7 billion	,
Revenue Growth (YoY)	+8.7%	,

Market Position and Capitalization

As of late August 2026, HCA's market capitalization was approximately $92 billion, positioning it as one of the larger constituents within global healthcare services equities. The company's scale, geographic reach, and diversified service mix contribute to its position as a benchmark name for investors tracking hospital sector performance.

Traders monitoring the broader 2026 Stocks Market Outlook will find HCA a useful reference point for understanding how healthcare services companies respond to macroeconomic pressures, including interest rate movements and shifts in consumer demand for elective procedures.

For context on sectoral comparisons, commercial insurers such as Elevance Health, Inc. operate on the payer side of the same ecosystem in which HCA functions as a provider, making the relationship between hospital operators and insurance companies a relevant structural consideration when assessing HCA's revenue visibility.

Last updated: 2026-09-04

Key Insights

HCA's Q2 2026 revenue of $20.23 billion represented 8.7% year-over-year growth, confirming that its scale advantage translates into durable top-line expansion even in a complex reimbursement environment.
The company's July 2026 guidance revision, lowering full-year diluted EPS guidance while narrowing revenue guidance, illustrates that payer mix pressures and uninsured volume can compress profitability even when revenue is rising, a distinction critical for earnings-season positioning.
At a market capitalization near $92 billion, HCA occupies a dominant share of the for-profit hospital sector; its size creates both a competitive moat through purchasing power and a ceiling on the growth multiples the market is willing to assign.
HCA's adjusted EBITDA guidance of $15.4–$16.1 billion for 2026 implies that margin defense, not just revenue growth, is the central investment question for the stock in the current fiscal year.
Healthcare services stocks are sensitive to Treasury yields because higher discount rates compress valuation multiples on long-duration cash flows, making the prevailing 10-year yield environment a persistent macro overlay for HCA positioning.

Key Financials

Audited · SEC filings

Reported figures from the company’s latest SEC filings — each linked to its source filing and period.

$19.11B

Quarterly revenue

Q1 2026 · SEC 10-Q

$1.62B

Net income

Q1 2026 · SEC 10-Q

15.2%

Gross margin

Q2 2026 · FMP

$7.15

Diluted EPS

Q1 2026 · SEC 10-Q

Quarterly revenue

$20B

$19B

$18B

~$18.29BQ4 2024

$18.32BQ1 2025

$18.61BQ2 2025

$19.16BQ3 2025

~$19.51BQ4 2025

$19.11BQ1 2026

~ Q4 is not filed as a standalone quarter — it is the annual 10-K figure minus the three filed quarters.

Figures are from the company’s audited SEC filings; each carries its filing source and period. Not investment advice.

Machine-readable table — same figures, per-metric source

Metric	Value	Source
Quarterly revenue (Q1 2026)	$19.11B	SEC 10-Q
Net income (Q1 2026)	$1.62B	SEC 10-Q
Gross margin (Q2 2026)	15.2%	FMP
Diluted EPS (Q1 2026)	$7.15	SEC 10-Q

HCA's Competitive Position in the Hospital Sector

As of September 2026, HCA Healthcare's approximately $92 billion market capitalization makes it the dominant publicly traded for-profit hospital operator in the United States.

That scale is not merely a valuation statistic, it translates into purchasing power across labor contracts, medical supplies, and capital equipment that smaller regional competitors cannot match, creating a structural cost advantage that tends to widen during periods of industry-wide inflation.

The For-Profit Hospital Peer Group

Within the listed for-profit hospital universe, HCA has no direct peer of comparable size. The next tier of operators manages materially fewer beds and generates substantially lower revenue.

This relative absence of scale-equivalent competitors means HCA often trades as the de facto proxy for the entire sector, attracting institutional flows whenever investors form a view on hospital utilization trends, labor cost trajectories, or government reimbursement policy.

For a trader, this matters: HCA's price action can reflect broad sector sentiment as much as company-specific fundamentals, which complicates the task of isolating stock-specific catalysts from macro healthcare noise.

Positioning Within the Broader Healthcare Sector

Beyond the hospital peer group, traders rotating through healthcare sector exposure will encounter meaningfully different business models. Elevance Health, Inc. and comparable managed care organizations bear premium and claims risk, their profitability is determined by the spread between insurance premiums collected and medical costs paid out, a dynamic called

the medical loss ratio. CVS Health Corporation operates across pharmacy benefit management, retail pharmacy, and care delivery, exposing investors to a diversified but complex mix of reimbursement, distribution, and clinical margin risks. Abbott Laboratories offers exposure to medical devices and diagnostics, where

revenue is driven by procedure volumes and product innovation cycles rather than payer contracts.

Each of these represents a distinct risk-return profile within a single sector classification. The table below summarizes the structural differences:

Business Model	Primary Cost Risk	Primary Revenue Driver	Operating Leverage Profile
HCA (for-profit hospital)	Clinical labor, facility capex	Inpatient/outpatient volumes, payer mix	High fixed-cost base
Managed care (e.g., Elevance)	Claims and premium risk	Insurance premiums, membership	Lower capital intensity
Pharmacy/care delivery (e.g., CVS)	Drug cost, distribution	Prescription volume, PBM fees	Mixed
Medical devices (e.g., Abbott)	R&D, manufacturing	Procedure volumes, innovation	High R&D fixed cost

Traders rotating between hospital operators and managed care organizations are taking on distinctly different operating leverage profiles. HCA's cost structure is dominated by staffing, nursing, clinical technicians, and support staff, and the depreciation of physical facilities. A surge in wage inflation or a drop in elective procedure volumes flows directly into margins.

Insurers, by contrast, can partially offset rising medical costs through premium repricing in subsequent contract cycles, a buffer that hospital operators do not have.

Network Effects and Regulatory Exposure

HCA's regional dominance in its core markets generates network effects that compound its competitive position. A hospital system controlling a significant share of beds and specialist relationships in a local market commands stronger referral flows from affiliated physicians and greater leverage in contract negotiations with commercial payers.

These dynamics reinforce revenue stability but also attract regulatory attention focused on hospital market concentration and its effect on pricing.

Analyst Sentiment: Q2 2026 Earnings Tension

Post-earnings commentary following Q2 2026 reflected a specific tension. Revenue growth of 8.7% year over year came in above consensus expectations, yet the company revised its full-year guidance, with adjusted EBITDA now expected in the range of $15.4 billion to $16.1 billion.

Analyst focus shifted to whether margin recovery was achievable within that range, a question that frames the key fundamental debate for the stock heading into the second half of 2026. Traders monitoring HCA's price exposure should track quarterly margin disclosures as the primary signal for resolving this uncertainty.

Broader macroeconomic dynamics, including the risks outlined in the Global Growth Downgrade Stagflation Risk theme, add a layer of demand-side uncertainty relevant to all hospital operators.

Why Trade HCA? Key Drivers, Catalysts, and Risks

HCA Healthcare's stock price is shaped by a distinct set of operating, regulatory, and macroeconomic forces that interact in ways not always visible in headline revenue numbers. A trader taking a CFD position on HCA must understand these dynamics before sizing any trade, because the stock can gap materially on guidance revisions even when top-line results come in ahead of consensus.

Primary Price Drivers

Four variables dominate HCA's earnings translation from quarter to quarter: payer mix, government reimbursement rates, uninsured patient volume, and cost inflation across labor and supplies.

Payer mix is the most immediate margin lever. Commercial insurance contracts reimburse at rates substantially above Medicare and Medicaid. When uninsured admissions rise, often reflecting broader macroeconomic stress, such as job losses reducing employer-sponsored coverage, revenue per patient day declines and bad-debt expense increases simultaneously.

The inverse is also true: a tighter labor market with high insurance coverage benefits HCA's realized revenue even without an increase in patient volume.

Government reimbursement decisions are a structural constant. Annual updates to Medicare inpatient prospective payment rates and Medicaid managed-care contract terms flow directly into HCA's blended revenue per adjusted admission.

Changes to the Affordable Care Act's coverage provisions or state-level Medicaid expansion decisions can alter the insured population HCA serves across its geographic footprint, with effects that compound over multiple fiscal years rather than a single quarter.

The July 2026 Guidance Revision: A Case Study in Catalyst Risk

The July 14, 2026 guidance revision illustrates the asymmetric risk inherent in trading hospital stocks around earnings. HCA lowered its full-year 2026 diluted EPS guidance range to $28.70–$30.50, citing pressure from uninsured volume and payer mix deterioration.

The revision came alongside Q2 2026 revenue of $20.23 billion, an 8.7% year-over-year increase that, in isolation, would be considered strong. Yet the forward commentary on mix and volume drove a negative price reaction, demonstrating that top-line beats can coexist with earnings disappointments when cost absorption and mix headwinds are present.

This dynamic is particularly relevant for leveraged CFD positions: guidance-driven gaps can bypass intraday stop-loss levels set before the announcement, and the speed of the move can be disproportionate to the magnitude of the EPS revision itself.

Interest Rate Sensitivity

HCA is a capital-intensive business. The company finances its hospital network, equipment, and real estate with long-duration debt, making its valuation and interest expense sensitive to Treasury yield movements. As of September 2026, the US 10-year Treasury yield stood at 4.79%, according to data from the Federal Reserve Bank of St. Louis.

Elevated yields affect HCA along two channels: higher borrowing costs on floating-rate or newly issued debt reduce free cash flow available for buybacks and capital expenditure, and higher discount rates compress the present value of future earnings streams in standard valuation models. Both effects can weigh on price-to-earnings multiples even when operational results are stable.

Macro and Thematic Overlays

Beyond company fundamentals, HCA attracts trading interest as a proxy for broader themes. Stagflation risk and global growth concerns can suppress consumer healthcare utilization as households defer elective procedures, a direct headwind to outpatient volume and surgery center revenues.

Separately, the application of AI-driven tools to hospital administration and clinical workflows is an evolving theme: meaningful labor cost reduction in clinical documentation, revenue-cycle management, and supply-chain optimization could eventually improve HCA's margin profile, though tangible financial effects remain difficult to quantify from public

disclosures.

Risk Summary for Leveraged Traders

The table below organizes HCA's key risk factors by type and time horizon.

Risk Factor	Nature	Typical Trigger
Earnings guidance revision	Episodic	Quarterly results and payer-mix commentary
Medicare/Medicaid rate changes	Structural	Annual regulatory cycles, legislation
Uninsured volume deterioration	Cyclical	Unemployment, ACA coverage changes
Interest rate environment	Macro	Federal Reserve policy, Treasury market
Labor cost inflation	Operational	Nursing shortages, wage competition
Elective procedure deferral	Cyclical	Consumer confidence, macro slowdown

For a CFD trader, the practical implication is that HCA requires monitoring on multiple calendars simultaneously: earnings dates, CMS reimbursement announcement windows, and Federal Reserve meeting schedules can all generate price volatility independently.

The stock trades on a scheduled session, closed at weekends and on market holidays, so the gap-risk from announcements made outside regular hours is a relevant position-management consideration. Session and holiday details are shown on the platform before you trade.

Valuation & peers

Multiples vs peers + third-party analyst targets

Peer Valuation Comparison

How this stock trades versus comparable listed companies on trailing valuation multiples.

Company	Market cap	P/E	P/S
HCA Healthcare, Inc. · HCA	$92.4B	14.3x	1.2x
Pfizer Inc. · PFE	$158.0B	36.6x	2.5x
Vertex Pharmaceuticals Incorporated · VRTX	$130.8B	29.8x	10.4x
Bristol-Myers Squibb Company · BMY	$130.0B	14.0x	2.6x
CVS Health Corp. · CVS	$120.8B	24.7x	0.3x
Medtronic plc · MDT	$116.4B	22.2x	3.1x

Third-party ratios (FMP), trailing twelve months. Multiples vary by data window; a negative or absent P/E means the company is loss-making. Not investment advice.

Analyst Price Targets

Buy

Wall Street sell-side analysts’ consensus 12-month price target and rating for this stock.

Consensus target

$455.19+6.4%

Target range

$369.00 – $579.00

Price-target coverage

16 analysts

Analyst ratings (46)

Buy 29Hold 15Sell 2

Targets by firm

Latest target from each of the 15 firms whose call was reported in the past 180 days. Each row links to the report.

Firm	Target	vs current
Goldman Sachs2026-07-28 · TheFly	$485.00	+13.4%
UBS2026-07-27 · TheFly	$579.00	+35.4%
Deutsche Bank2026-07-27 · TheFly	$476.00	+11.3%
Morgan Stanley2026-07-27 · TheFly	$380.00	-11.2%
Oppenheimer2026-07-27 · TheFly	$485.00	+13.4%
Robert W. Baird2026-07-27 · TheFly	$393.00	-8.1%
Barclays2026-07-27 · TheFly	$387.00	-9.5%
KeyBanc2026-07-27 · TheFly	$435.00	+1.7%
Wells Fargo2026-07-20 · TheFly	$369.00	-13.7%
RBC Capital2026-07-15 · TheFly	$435.00	+1.7%
Jefferies2026-07-14 · TheFly	$450.00	+5.2%
Raymond James2026-07-07 · StreetInsider	$528.00	+23.4%
Cantor Fitzgerald2026-07-07 · TheFly	$525.00	+22.7%
Truist Financial2026-06-04 · StreetInsider	$413.00	-3.4%
Bernstein2026-06-04 · TheFly	$413.00	-3.4%

Source: aggregated sell-side analyst consensus · as of 2026-09-13. These are third-party analyst opinions — not CoinUnited’s view, not a price prediction, and not investment advice.

Scenario calculator

Pick a third-party reference level and see what it implies at leverage. Reference levels only - not a CoinUnited forecast.

Scenario price

$426.06

+0.0% vs current

Your margin (USD)Leverage

Position size $100,000.00

P&L at this scenario (long)

+$0.00

Loss if liquidated -$1,000.00 (the full margin)

Liquidation price (long): $421.80 — a move of -1.0%

Trade HCA

Simplified: excludes fees, funding and slippage. Reference levels are third-party marks (CoinUnited daily kline; aggregated sell-side analyst targets), not forecasts. Leverage magnifies losses as much as gains - at high leverage a small adverse move liquidates the position. Not investment advice.

Catalysts & news

Dated third-party developments · newest first

Catalyst Timeline

Dated third-party developments that move the stock — newest first, each classified bullish or bearish and linked to its source.

2026-10-22
Next quarterly earnings◆ Scheduled
Next scheduled quarterly earnings report (2026-10-22). Revenue, margins and guidance are the near-term driver; the outcome is not known in advance.
Finnhub
2026-07-29
HCA raises guidance on strong surgical demand▲ Bullish
HCA Healthcare raised its yearly profit and revenue forecasts on Friday on sustained demand for surgical procedures as well as strength in its Medicare business, sending its shares up 4% to $460.12.
Reuters
2026-07-14
HCA scales back guidance on payer shifts▼ Bearish
HCA Healthcare’s HCA -1.03%decrease; shares were under pressure after the for-profit operator of healthcare facilities scaled back financial guidance for the year following payer mix shifts due to health insurance exchanges.
The Wall Street Journal
2026-01-27
HCA expects 2026 profits to beat forecasts▲ Bullish
On January27 () -CA HealthcareHCA.N) announced on Tuesday that it anticipates its profits for 2026 will surpass Wall Street predictions, following a quarterly earnings report that exceeded expectations due to strong demand for medical…
Reuters
2025-10-24
HCA Healthcare beats Q3 earnings expectations▲ Bullish
On October 24 (Reuters) - The hospital management firm HCA Healthcare (HCA.N) surpassed Wall Street's expectations for its third-quarter earnings on Friday, driven by robust demand for its healthcare services.
Reuters
2025-10-24
HCA raises full-year forecast on Q3 gains▲ Bullish
HCA Healthcare saw a 2.67% rise in its shares, as the company raised its annual forecast following an increase in both profit and revenue during the third quarter, driven by growth in same-facility admissions.
The Wall Street Journal
2025-10-24
HCA revenue rises 9.6% to $19.16 billion▲ Bullish
## Revenue rose 9.6% to $19.16 billion ET ... HCA Healthcare HCA -2.39%decrease; lifted its full-year outlook after logging higher profit and revenue in the third quarter, as same-facility admissions grew.
The Wall Street Journal

Machine-readable table — same developments, with source

Recent third-party developments classified bullish / bearish for the stock; verbatim, sourced.

Date	Development	Direction	Source
2026-10-22	Next scheduled quarterly earnings report (2026-10-22). Revenue, margins and guidance are the near-term driver; the outcome is not known in advance.	◆ Scheduled	Finnhub
2026-07-29	HCA Healthcare raised its yearly profit and revenue forecasts on Friday on sustained demand for surgical procedures as well as strength in its Medicare business, sending its shares up 4% to $460.12.	▲ Bullish	Reuters
2026-07-14	HCA Healthcare’s HCA -1.03%decrease; shares were under pressure after the for-profit operator of healthcare facilities scaled back financial guidance for the year following payer mix shifts due to health insurance exchanges.	▼ Bearish	The Wall Street Journal
2026-01-27	On January27 () -CA HealthcareHCA.N) announced on Tuesday that it anticipates its profits for 2026 will surpass Wall Street predictions, following a quarterly earnings report that exceeded expectations due to strong demand for medical…	▲ Bullish	Reuters
2025-10-24	On October 24 (Reuters) - The hospital management firm HCA Healthcare (HCA.N) surpassed Wall Street's expectations for its third-quarter earnings on Friday, driven by robust demand for its healthcare services.	▲ Bullish	Reuters
2025-10-24	HCA Healthcare saw a 2.67% rise in its shares, as the company raised its annual forecast following an increase in both profit and revenue during the third quarter, driven by growth in same-facility admissions.	▲ Bullish	The Wall Street Journal
2025-10-24	## Revenue rose 9.6% to $19.16 billion ET ... HCA Healthcare HCA -2.39%decrease; lifted its full-year outlook after logging higher profit and revenue in the third quarter, as same-facility admissions grew.	▲ Bullish	The Wall Street Journal

Key Takeaways

Last updated: 2026-07-24

•FY2026 EPS guidance midpoint of $30.30 exceeds LSEG consensus of ~$29.46 by ~2.8%, driving the bullish re-rating thesis for HCA Healthcare CFDs.
•Leveraged long positions face real liquidation risk: a 50x HCA CFD at $378.60 is fully margined out on a ~2% adverse move — size carefully given the 24h low of $365.12.
•The $10B share buyback and $400M cost-savings plan provide structural EPS support, reducing downside risk for medium-term leveraged positions.
•Cross-market: Strong HCA admissions data signals elevated healthcare utilization — bullish for hospital operators, mixed for managed care/insurers facing higher claims.
•The market has shown it grades HCA on volume and EBITDA quality, not just headline beats — Q1 2026's in-line print triggered a ~6.7% selloff, so admissions trajectory is the key watch item.

Latest Pulses

2026-07-24StocksBullish

HCA

HCA Healthcare Beats Estimates & Raises FY2026 Outlook — What It Means for Leveraged Healthcare CFD Traders

HCA Healthcare (NYSE: HCA) delivered a multi-quarter pattern of earnings beats alongside a FY2026 guidance update that exceeded Wall Street consensus. As reported by Reuters, HCA's Q4 2025 revenue rea

2026-04-27StocksBearish

HCA

KeyBanc Slashes HCA Healthcare Target to $510 Amid Broad Analyst Downgrades After Weak Quarter

HCA Healthcare, Inc. (NYSE: HCA) — the largest U.S. private hospital operator with 190 hospitals and 121 surgery centers — has drawn a wave of analyst price target cuts following a disappointing quart

View all HCA pulses

Ownership

Top institutional holders (SEC Form 13F)

Top Institutional Holders

SEC 13F

The largest institutional shareholders, from SEC Form 13F filings — who holds the stock and how much.

Institution	Shares	Value	% of shares
BlackRock, Inc.	13.4M	$6.3B	6.02%
Vanguard Capital Management LLC	10.2M	$4.8B	4.59%
Sanders Capital, LLC	9.0M	$4.2B	4.04%
State Street Corp.	7.5M	$3.6B	3.40%
FMR LLC	4.4M	$2.1B	1.98%
Wellington Management Group LLP	3.9M	$1.8B	1.76%
Geode Capital Management, LLC	3.7M	$1.7B	1.66%
First Eagle Investment Management, LLC	3.3M	$1.5B	1.47%
Capital International Investors	3.0M	$1.4B	1.37%
Vanguard Portfolio Management LLC	2.8M	$1.3B	1.24%

Source: SEC Form 13F filings · 1405 institutional holders · as of 31-MAR-2026. 13F data is quarterly and lagged (filed ~45 days after quarter-end) and covers US institutional managers (>$100M AUM) only — not insiders, retail, or foreign holders. Not investment advice.

Understand the risks

Read before trading

Trading Risks

An honest, up-front list of the risks — both out of respect for the trader and as a YMYL compliance requirement.

Leverage / Liquidation

High leverage means a small adverse move can trigger forced liquidation and loss of your full margin.

High-valuation volatility

A high P/E stock is very sensitive to interest-rate and narrative shifts; swings can be large.

Session gaps

After-hours and weekend gaps; extended-hours liquidity is thinner than the regular session.

Basis risk

The CFD reference price can diverge from the exchange execution price.

Earnings volatility

Price swings widen around earnings dates and other scheduled disclosures.

Regulatory / event

Recalls, policy changes, or company-specific events can cause sharp moves.

Reference

FAQ & glossary

Frequently Asked Questions

HCA Healthcare is one of the largest for-profit hospital and healthcare services operators in the United States. The company owns and operates a broad network of hospitals, surgery centers, emergency rooms, urgent care facilities, and physician clinics. Its facilities span multiple states and are concentrated in high-growth markets in the South and West. The business model centers on providing inpatient and outpatient care across a wide spectrum of medical specialties, including cardiovascular, orthopedic, oncology, and women's health services. Revenue flows primarily from patient services billed to commercial insurers, Medicare, Medicaid, and self-paying patients. The mix among those payers is a key driver of financial performance, because commercial insurance typically reimburses at higher rates than government programs. HCA also invests in physician practice management, clinical technology, and supply chain infrastructure to support operational efficiency across its hospital network. The company trades on the New York Stock Exchange under the ticker HCA.

Glossary

Key listed-stock and CFD terms, one line each — so the page is unambiguous for both readers and AI answer engines.

Stock CFD	A contract for difference on a share price — price exposure only, not ownership of the underlying shares.
Extended hours	Pre-market and after-hours trading outside the exchange’s regular session.
Basis risk	The risk that the CFD reference price and the exchange execution price do not move in step.
P/E	Price-to-earnings ratio = share price ÷ earnings per share; a common valuation gauge.
Gross margin	Gross profit ÷ revenue; reflects product-level profitability.
EPS	Earnings per share = net income ÷ diluted shares outstanding.

symbol

HCA

Markets

Stocks

Sector

Healthcare

CU Product Code

HCA

Source Map

Every figure on this page traces to a primary or named third-party source. "As of" dates the source; "last checked" dates our most recent read of it.

Every figure here is also published as machine-readable data, and re-checked on a schedule so a stale one shows up as stale. View the raw data

Field	Value	Source	As of	Last checked
Reference price	live	CoinUnited stock CFD reference (live)	—	—	—
Market cap	$95B	CoinUnited reference x SEC shares	2026-09-13	2026-09-13	—
P/E	~15.1	CoinUnited reference / SEC annual EPS	—	2026-09-13	—
52-week range	$349.32 – $556.39	CoinUnited daily kline	—	2026-09-13	—
Next earnings	2026-10-22	Finnhub	—	2026-09-13	—
Quarterly revenue	$19.11B	SEC 10-Q	Q1 2026	2026-09-13	View
Net income	$1.62B	SEC 10-Q	Q1 2026	2026-09-13	View
Gross margin	15.2%	FMP	Q2 2026	2026-09-13	View
Diluted EPS	$7.15	SEC 10-Q	Q1 2026	2026-09-13	View
Institutional ownership	10 top holders	SEC Form 13F	31-MAR-2026	2026-09-13	View
Analyst price targets	$455.19 consensus	Aggregated sell-side analyst consensus	2026-09-13	2026-09-13	—
Peer valuations	6 peers	Third-party ratios (FMP), trailing twelve months	2026-09-13	2026-09-13	—
Founded	1968	Wikidata	—	2026-09-13	—
Headquarters	Nashville	Wikidata	—	2026-09-13	—
Industry	health care	Wikidata	—	2026-09-13	—
CoinUnited product	Stock CFD — price exposure, not equity (no voting; dividends reflected as adjustment); leverage available	CoinUnited product terms	—	2026-09-13	—

About the Author

CoinUnited.io Research Team

This page is compiled by CoinUnited.io's research team: analysts covering listed equities and global markets, working from primary filings and named third-party data rather than opinion.

Our Research Methodology

Every figure is traced to a primary or named third-party source and dated: financial statements from the company's SEC filings, institutional ownership from Form 13F, analyst targets from aggregated third-party coverage, and market data from the CoinUnited reference price. The Source Map on this page lists each one with its source and the date we last checked it.

Disclaimer: content is for informational and educational purposes only and is not personalized financial advice. A stock CFD carries significant risk and provides price exposure only, not equity ownership. Always conduct your own research and consult a qualified financial advisor.

Disclaimers & References

Important Risk Disclaimer

A CoinUnited stock CFD gives price exposure to HCA Healthcare, Inc. only, not equity ownership: no shareholder voting rights, no dividends, and no settlement in the underlying share.

Leverage magnifies losses as well as gains, and a position can be liquidated long before the underlying share price recovers. The underlying listing trades on exchange hours, so the reference price can gap between sessions.

Users should conduct their own research and consult with qualified financial professionals before making any investment decisions. The creators and operators of this platform assume no responsibility for any financial losses or other damages that may result from reliance on the information provided.

Leveraged trading is extremely risky and you may lose your entire deposit.

Methodology Overview

Figures on this page are compiled from primary and named third-party sources, not produced by a forecasting model. Each one carries its source and date in the Source Map above.

Financial statements: the company's own SEC filings (10-K / 10-Q), read from XBRL
Market data: the CoinUnited reference price and daily closes
Institutional ownership: SEC Form 13F quarterly filings
Analyst targets: aggregated third-party sell-side coverage — third-party opinion, not CoinUnited's view
Peer multiples: third-party trailing-twelve-month ratios

CoinUnited does not publish a price forecast or target for HCA Healthcare, Inc..

Last methodology review:

Ready to Start Trading HCA Healthcare, Inc.?

Join thousands of traders and start your HCA Healthcare, Inc. trading journey today. Get access to advanced trading tools and competitive fees.

Trade HCA/USDT Sign Up Now

HCA

HCA Healthcare, Inc.

$426.06

▼-0.38%24h

24h Low24h High

$419.91$434.03

Bid

$425.82

Ask

$426.30

Trade Now

Up to 800x leverage•Tiered fees

Live from CoinUnited.io

HCA

$426.06-0.38%

Trade Now

Navigate to Other Instruments

Quick Links

Position Calculator

HCA Healthcare, Inc.

How to trade it

Trading Regime Status

How the HCA CFD works

Trading conditions on CoinUnited

Trading HCA Healthcare CFDs on CoinUnited.io

Session Structure and Gap Risk

Earnings Events as Discrete Volatility Catalysts

Leverage Mechanics: A Worked Example

Fee Considerations for Short-Term Positioning

Ready to Trade HCA?

Key facts & how to trade

Access & Tradability Comparison

Key Facts

Price & Market Structure

Company & financials

What Is HCA Healthcare, Inc. (HCA)?

Business Model and Revenue Structure

Financial Scale: Q2 2026 and Full-Year Guidance

Market Position and Capitalization

Key Insights

Key Financials

Quarterly revenue

HCA's Competitive Position in the Hospital Sector

The For-Profit Hospital Peer Group

Positioning Within the Broader Healthcare Sector

Network Effects and Regulatory Exposure

Analyst Sentiment: Q2 2026 Earnings Tension

Why Trade HCA? Key Drivers, Catalysts, and Risks

Primary Price Drivers

The July 2026 Guidance Revision: A Case Study in Catalyst Risk

Interest Rate Sensitivity

Macro and Thematic Overlays

Risk Summary for Leveraged Traders

Valuation & peers

Peer Valuation Comparison

Analyst Price Targets

Targets by firm

Scenario calculator

Catalysts & news

Catalyst Timeline

Key Takeaways

Latest Pulses

HCA Healthcare Beats Estimates & Raises FY2026 Outlook — What It Means for Leveraged Healthcare CFD Traders

KeyBanc Slashes HCA Healthcare Target to $510 Amid Broad Analyst Downgrades After Weak Quarter

Ownership

Top Institutional Holders

Understand the risks

Trading Risks

Reference

Frequently Asked Questions

1. What is HCA Healthcare and what does it do?

2. How large is HCA Healthcare by revenue and market capitalization?

3. What were HCA Healthcare's Q2 2026 earnings results?

4. Why did HCA Healthcare lower its full-year 2026 guidance in July 2026?

5. What is payer mix and why does it matter for HCA's profitability?

6. How does Medicare and Medicaid reimbursement affect HCA Healthcare's stock price?

7. What is uninsured patient volume and how does it impact HCA's margins?

8. How does HCA Healthcare compare to Tenet Healthcare as an investment?

9. Is HCA Healthcare a growth stock or a value stock?

10. What are the main risks of investing in for-profit hospital companies like HCA?

11. How sensitive is HCA Healthcare's stock to interest rate changes?

12. What is HCA Healthcare's adjusted EBITDA and why do analysts focus on it?

13. How does HCA Healthcare generate revenue — inpatient versus outpatient?

14. What is the difference between HCA Healthcare CFDs and buying HCA shares?

15. How does weekend gap risk affect HCA Healthcare CFD traders?

16. What happens to an HCA CFD position during US market holidays?

17. How does leverage work when trading HCA Healthcare CFDs?

18. What is the maximum leverage for HCA Healthcare CFDs on CoinUnited?

19. How do earnings releases affect HCA Healthcare's stock price volatility?

20. How do I calculate position size when trading HCA Healthcare with leverage?

Glossary

symbol

Markets

Sector

CU Product Code

Tags